Published November 15, 2012
Intarcia Therapeutics said it raised $210 million, enabling the biotechnology company to fund late-stage clinical trials for a new diabetes treatment without forming an alliance with a major drug maker. [ read more ]
Utah Business Social
Banking on Women™ ProgramSep 4, 2014Westminster Seeks Female Entrepreneurs for Free Training Program
Revolutionary Banking on Women™...